Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy

Overview of attention for article published in Cochrane database of systematic reviews, December 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter: 9 tweeters

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 60 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study

Article in BMC Nephrology (January 2023)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care

Article in Journal of Critical Care (December 2022)

Guidelines for the anticoagulant management of continuous renal replacement therapy

Article in Chinese Journal of Nephrology (November 2022)